Shots:

• The collaboration will combine Genialis’ expressions software platform and analytics IP with Oncologie’s clinical and translational expertise to refine patient stratification methodologies
• The companies will initially focus on modeling gene expression signatures predictive of treatment for gastric cancer. The methodology will further enhance Oncologie’s clinical development plans to expand beyond gastric cancer
• Genialis merges and models data at the intersection of clinical and translational medicine- utilizing blending computational biology and AI-based method. Additionally- Genialis to present its work on predictive models for patient stratification at the Precision Medicine World Conference in CA

Click here to­ read full press release/ article | Ref: Businesswire | Image:  Genialis